| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |